Trends in Endocrinology & Metabolism
ReviewEpigenetic mechanisms in the development of type 2 diabetes
Introduction
The incidence of type 2 diabetes (T2D) has rapidly increased over the past several decades and is now reaching epidemic proportions across the globe. In fact, incidence of T2D is estimated to reach 366 million throughout the world by 2030 [1]. Simple Mendelian inheritance patterns have failed to describe the genetics of T2D, in that studies have identified single nucleotide polymorphisms linked to the development of T2D, but no disease-causing mutations have been discovered. Recent genome-wide association studies identified at least 17 genetic loci associated with T2D [2], suggesting that T2D is a complex genetic disorder influenced by interactions between multiple susceptible genetic loci and environmental perturbations.
Environmental contributions to the development of T2D potentially include exposures such as a suboptimal in utero environment, low birth weight, obesity, inactivity and advancing age [3]. These environmental perturbations can lead to a disease phenotype by affecting gene expression through epigenetic modifications. Epigenetic changes are defined as mitotically heritable alterations in gene expression that are not related to changes in DNA sequence. One of the key environmental perturbations associated with T2D is exposure to an adverse intrauterine milieu, such as intrauterine growth retardation (IUGR). An adverse intrauterine milieu affects fetal development by modifying gene expression of both pluripotent cells that are rapidly replicating and terminally differentiated cells that replicate poorly. Whether the effect(s) of exposure to an altered intrauterine milieu extend into adulthood depends on whether the cells are undergoing differentiation, proliferation and/or functional maturation at the time of that exposure.
There are several examples where human exposure to an abnormal intrauterine milieu leads to abnormalities in glucose homeostasis and ultimately T2D. For example, pregnant women exposed to the Dutch Hunger Winter, the period in late World War II during which daily caloric intake was limited to 400–800 kcal, delivered infants with lower birth weights. By age 50, these offspring had impaired glucose tolerance compared to offspring who were in utero either the year before or after the famine [4]. Another epidemiological study from Hertfordshire, UK found that men who were the smallest at birth (<2.5 kg) were seven times more likely to have glucose intolerance or T2D than those who were heaviest at birth [5]. Permanent changes in the phenotype of the offspring suggest that IUGR is associated with stable changes in gene expression, potentially as a result of epigenetic modifications. Here, we provide a general review of epigenetics and discuss the possible causal role of chromatin remodeling in the development of T2D.
Section snippets
Chromatin structure, DNA methylation and gene expression
Epigenetic modifications of the genome provide a mechanism that allows the stable propagation of gene expression from one generation of cells to the next 6, 7, 8, 9, 10, 11, 12, 13, 14. There are at least two distinct mechanisms through which epigenetic information can be inherited: histone modifications and DNA methylation.
Maternal nutritional supplementation and epigenetic modifications in offspring
The role of environmental regulation of epigenetic phenomena in offspring has been established by experiments performed in agouti mice (reviewed in Ref. [20]). Wild type expression of the Agouti protein results in a phenotypic brown coat color in the mouse. In this mouse model, an endogenous retrovirus-like transposon sequence is inserted close to the gene coding for the Agouti protein. An unmethylated retrotransposon promoter overrides the wild type agouti promoter, resulting in ectopic agouti
Chromatin remodeling and oxidative stress
Exposure to oxidative stress can directly mediate both DNA methylation and chromatin remodeling in multiple disease models and thus could be a mechanism by which aberrant epigenetic programming leads to T2D 15, 16, 17, 18, 19, 20, 21, 22, 23, 24. In addition to targeted DNA methylation changes in response to external stimuli, random DNA methylation changes also occur during aging in several tissue types and are associated with increased oxidative stress 16, 23. Such changes in DNA methylation
Epigenetic regulation of gene expression in fetal growth retardation
Several studies suggest that uteroplacental insufficiency, the most common cause of IUGR in the developed world, induces epigenetic modifications in offspring 35, 36, 37, 38. Fetal growth retardation can be induced by bilateral uterine artery ligation in the pregnant rat [39]. Following this, pups are born spontaneously with decreased levels of glucose, insulin, insulin-like growth factor 1 and amino acids [39]. Diabetes develops in these animals at approximately 15–26 weeks of age with
Chromatin remodeling in the β-cell of IUGR rats
Pdx-1 is a homeodomain-containing transcription factor that plays a critical role in the early development of both the endocrine and exocrine pancreas and in the later differentiation and function of the β-cell. As early as 24 h after the onset of growth retardation, Pdx-1 mRNA levels are reduced by more than 50% in IUGR fetal rats. Suppression of Pdx-1 expression persists after birth and progressively declines in the IUGR animal, implicating an epigenetic mechanism.
A change in histone
Chromatin remodeling in muscle of IUGR rats
Reduced glucose transport in muscle is a trademark of insulin resistance in IUGR offspring 47, 48. Under normal physiological circumstances, glucose transport occurs by facilitated diffusion, a rate-limiting step in glucose utilization [49]. This process of glucose transport is mediated by a family of structurally related membrane-spanning glycoproteins, termed facilitative glucose transporters (GLUTs; Slc2 family of transport proteins; reviewed in Ref. [50]). Of the isoforms cloned to date,
Histone modifications in vascular epithelium exposed to hyperglycemia
The previous examples describing the relationship between chromatin remodeling and its contribution to the development of T2D focused on the IUGR animal model. We focused on this model because it is the only system that has thus far been able to link specific chromatin modifications to changes in gene expression relevant to alterations in glucose homeostasis in vivo. Brasacchio et al. describe how transient hyperglycemia in vitro induces changes in histone methylation at the promoter of
T2D therapeutic agents targeting chromatin remodeling
Drugs that are currently used to treat patients with T2D have been shown to reverse epigenetic modifications in vitro. Treating INS1 (832/13) β-cells (a rat insulinoma cell line) or dispersed mouse islets with incretin hormones such as glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic-peptide 1 (GIP) increased global acetylation of histone H3 at lysine residues 9 and 18 and increased phosphorylation at serine 10 in a concentration-dependent manner [55]. These histone
Concluding remarks
The studies described above clearly show that environmental effects can induce epigenetic alterations, ultimately affecting expression of key genes linked to the development of T2D including genes critical for pancreatic development and β-cell function, peripheral glucose uptake and insulin resistance, and atherosclerosis. Recent progress in understanding epigenetic programming of gene function has led to the development of novel therapeutic agents with epigenetic targets in diseases such as
Acknowledgments
Dr. Rebecca Simmons is supported by the National Institutes of Health grant #DK55704. Dr. Pinney is supported by the National Institutes of Health Training Grant K12HD0432545.
References (61)
Obesity at the age of 50 y in men and womenexposed to famine prenatally
Am. J. Clin. Nutr.
(1999)The dynamics of chromatin remodeling at promoters
Mol. Cell
(2005)Genomic and epigenetic instability in colorectal cancer pathogenesis
Gastroenterology
(2008)Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring
J. Nutr.
(2002)Decline in genomic DNA methylation through aging in a cohort of elderly subjects
Mech. Ageing Dev.
(2009)Oxidative stress, DNA methylation and carcinogenesis
Cancer Lett.
(2008)Hypoxia-induced oxidative base modifications in the VEGF hypoxia-response element are associated with transcriptionally active nucleosomes
Free Radic. Biol. Med.
(2009)4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease
Neurosci. Lett.
(2004)- et al.
An epigenetic perspective on the free radical theory of development
Free Radic. Biol. Med.
(2007) Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress
J. Biol. Chem.
(2001)
Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic β-cells
Biochem. Biophys. Res. Commun.
Progressive accumulation of mitochondrial DNA mutations and decline in mitochondrial function lead to beta-cell failure
J. Biol. Chem.
Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring
J. Biol. Chem.
Pancreatic islet expression of the homeobox factor STF-1 (Pdx-1) relies on an E-box motif that binds USF
J. Biol. Chem.
The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells
J. Biol. Chem.
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Cancer Cell
Histone methylation in transcriptional control
Curr. Opin. Genet. Dev.
Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell
Mol. Cell. Endocrinol.
Differential regulation of the muscle-specific GLUT4 enhancer in regenerating and adult skeletal muscle
J. Biol. Chem.
Atherosclerosis: the road ahead
Cell
Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 modulate β-cell chromatin structure
J. Biol. Chem.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
Diabetes Care
The genetics in type 2 diabetes: a realistic appraisal in 2008
J. Clin. Endocrinol. Metab.
Genetic determinants and molecular pathways in the pathogenesis of type 2 diabetes
Clin. Sci.
Fetal and infant growth and impaired glucose tolerance at age 64 years
Br. Med. J.
Reversing histone methylation
Nature
RNA meets chromatin
Genes. Dev.
The role of chromatin structure in regulating the expression of clustered genes
Nat. Rev. Genet.
Developmental pattern of gene-specific DNA methylation in the mouse embryo and germline
Genes Dev.
Temporal and regional changes in DNA methylation in the embryonic, extra-embryonic and germ cell lineages during mouse embryo development
Development
Cited by (159)
The beta cell failure in type 2 diabetes
2023, Medecine des Maladies MetaboliquesEarly origins of disease
2023, Encyclopedia of Human Nutrition: Volume 1-4, Fourth EditionEpigenetics of the developing and aging brain: Mechanisms that regulate onset and outcomes of brain reorganization
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Under conditions of poor maternal nutrition during fetal development the histone deacetylase complex mSin3/HDAC is recruited to the Pdx1 promoter in the pancreas. The loss of the histone acetylation at the Pdx1 promoter results in the loss of the transcription factor binding required for Pdx1 gene expression (Pinney and Simmons, 2010). Postnatally, a loss of the activating histone mark on histone 3 (H3) lysine 4 (K4) tri-methylation (me3) (H3K4me3), and an increase of the repressive H3 Lysine 9 (K9) di-methylation (me2) (H3K9me2), are seen at the Pdx1 gene promoter.
Excessive folic acid supplementation in pregnant mice impairs insulin secretion and induces the expression of genes associated with fatty liver in their offspring
2020, HeliyonCitation Excerpt :It has also been reported that consumption of a low-protein diet during gestation increases microRNA375 expression in β-cells, which negatively regulates their proliferation and insulin secretion [23], and induces mitochondrial dysfunction [24]. In addition, the adult offspring of mice that consume a low-energy diet during pregnancy demonstrate lower expression of insulin and the transcription factor insulin promoter factor (Pdx)-1, which induces insulin expression in the pancreas [25]. Thus, it is possible that excessive fetal FA exposure may have its effect via miR375 and Pdx-1 in β-cells, and this possible mechanism should be investigated in a future study.
Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression
2024, Critical Reviews in Biochemistry and Molecular Biology